Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2018-03-16 | 2018-07-30 | 43122 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2018-08-31 | 2018-10-20 | 59704 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-03-26 | 2020-05-14 | 109580 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113752 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113770 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2020-05-08 | 2020-05-14 | 114430 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2020-05-08 | 2020-05-14 | 114433 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-06-18 | 2020-08-21 | 118259 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-09-17 | 2020-11-19 | 124480 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2021-08-27 | 2021-09-16 | 144752 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163912 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-06-30 | 2023-06-09 | 163915 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163918 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2022-12-08 | 2023-04-28 | 177523 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-12-08 | 2023-06-09 | 177526 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2025-05-08 | 2025-06-27 | 256911 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2025-06-13 | 2025-07-03 | 260187 |
| TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2019-07-02 | 2020-08-21 | 88189 |
| TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88192 |
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2019-07-02 | 2020-08-21 | 88195 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 8MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258676 |
| ACT ENALAPRIL | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258682 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258697 |
| ACT FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258703 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266377 |
| TEVA-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266380 |
| TEVA-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266383 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |